The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Leif Groop

Leif Groop

Principal investigator

Leif Groop

DOLORisk : Study protocol for a multi-centre observational study to understand the risk factors and determinants of neuropathic pain [version 2; referees: 2 approved]


  • Mathilde M.V. Pascal
  • Andreas C. Themistocleous
  • Ralf Baron
  • Andreas Binder
  • Didier Bouhassira
  • Geert Crombez
  • Nanna B. Finnerup
  • Janne Gierthmühlen
  • Yelena Granovsky
  • Leif Groop
  • Harry L. Hebert
  • Troels S. Jensen
  • Kristinn Johnsen
  • Mark I. McCarthy
  • Weihua Meng
  • Colin N.A. Palmer
  • Andrew S.C. Rice
  • Jordi Serra
  • Romà Solà
  • David Yarnitsky
  • Blair H. Smith
  • Nadine Attal
  • David L.H. Bennett

Summary, in English

Background: Neuropathic pain is an increasingly prevalent condition and has a major impact on health and quality of life. However, the risk factors for the development and maintenance of neuropathic pain are poorly understood. Clinical, genetic and psychosocial factors all contribute to chronic pain, but their interactions have not been studied in large cohorts. The DOLORisk study aims to study these factors. Protocol: Multicentre cross-sectional and longitudinal cohorts covering the main causes leading to neuropathic pain (e.g. diabetes, surgery, chemotherapy, traumatic injury), as well as rare conditions, follow a common protocol for phenotyping of the participants. This core protocol correlates answers given by the participants on a set of questionnaires with the results of protocol for phenotyping of the participants. This core protocol correlates answers given by the participants on a set of questionnaires with the results of their genetic analyses. A smaller number of participants undergo deeper phenotyping procedures, including neurological examination, nerve conduction studies, threshold tracking, quantitative sensory testing, conditioned pain modulation and electroencephalography. Ethics and dissemination: All studies have been approved by their regional ethics committees as required by national law. Results are disseminated through the DOLORisk website, scientific meetings, open-access publications, and in partnership with patient organisations. Strengths and limitations: • Large cohorts covering many possible triggers for neuropathic pain • Multi-disciplinary approach to study the interaction of clinical, psychosocial and genetic risk factors • High comparability of the data across centres thanks to harmonised protocols • One limitation is that the length of the questionnaires might reduce the response rate and quality of responses of participants.


  • Genomics, Diabetes and Endocrinology
  • EXODIAB: Excellence of Diabetes Research in Sweden

Publishing year





Wellcome Open Research



Document type

Journal article


F1000 Research Ltd.


  • Neurosciences
  • Endocrinology and Diabetes


  • Diabetes
  • Nerve injury
  • Neuropathic pain
  • Neuropathy
  • Pain
  • Protocol
  • Risk factors



Research group

  • Genomics, Diabetes and Endocrinology


  • ISSN: 2398-502X